4.7 Article

PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma

Journal

Publisher

MDPI
DOI: 10.3390/ijms20184599

Keywords

angiogenesis; FGF-2; fibrosarcoma; inflammation; PTX-3

Funding

  1. Associazione Italiana per la Ricerca sul Cancro (AIRC) [MFAG-18459, IG-18943]
  2. FIRC-AIRC one-year fellowship Laura Bassi [20879]

Ask authors/readers for more resources

Fibrosarcoma is an aggressive subtype of soft tissue sarcoma categorized in infantile/congenital-type and adult-type. Fibrosarcoma cells and its surrounding immune inflammatory infiltrates overexpress or induce the expression of fibroblast growth factor-2 (FGF-2) that have a crucial role in tumor progression and angiogenesis. The inflammation-associated long pentraxin 3 (PTX3) was found to reduce FGF-2-mediated angiogenesis, but its role on fibrosarcoma immune inflammatory infiltrate is still unknown. In this study, we have evaluated the PTX3 activity on immune infiltrating mast cells, macrophages and T-lymphocytes by immunohistochemistry on murine MC-TGS17-51 fibrosarcoma cells and on transgenic TgN(Tie2-hPTX3) mouse. In these fibrosarcoma models we found a reduced neovascularization and a significant decrease of inflammatory infiltrate. Indeed, we show that PTX3 reduces the level of complement 3 (C3) deposition reducing fibrosarcoma progression. In conclusion, we hypothesize that targeting fibrosarcoma microenvironment by FGF/FGFR inhibitors may improve treatment outcome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

FGFR blockade by pemigatinib treats naive and castration resistant prostate cancer

Paola Chiodelli, Daniela Coltrini, Marta Turati, Marianna Cerasuolo, Federica Maccarinelli, Sara Rezzola, Elisabetta Grillo, Arianna Giacomini, Sara Taranto, Silvia Mussi, Alessia Ligresti, Marco Presta, Roberto Ronca

Summary: The study validates the therapeutic efficacy of the FDA-approved FGFR inhibitor pemigatinib in treating PCa and CRPC, and reveals its synergistic effect with enzalutamide in inhibiting tumor growth, providing valuable data support for the clinical application of this treatment approach.

CANCER LETTERS (2022)

Article Immunology

Autocrine/Paracrine Loop Between SCF+/c-Kit+ Mast Cells Promotes Cutaneous Melanoma Progression

Tiziana Annese, Roberto Tamma, Mariella Bozza, Alfredo Zito, Domenico Ribatti

Summary: c-Kit receptor is expressed and involved in various biological processes in mucosal mast cells, such as cell survival, proliferation, hematopoiesis, and melanogenesis. This study found that in melanoma, mast cells express and release SCF and c-Kit receptors, potentially regulating tumor progression through an autocrine/paracrine loop.

FRONTIERS IN IMMUNOLOGY (2022)

Article Medicine, General & Internal

The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells

Giuseppe Ingravallo, Roberto Tamma, Giuseppina Opinto, Tiziana Annese, Francesco Gaudio, Giorgina Specchia, Tommasina Perrone, Pellegrino Musto, Gerardo Cazzato, Emilio Bellitti, Saverio Capodiferro, Eugenio Maiorano, Domenico Ribatti

Summary: Lymphomas are tumors that grow in an inflammatory microenvironment, and the cells in this environment are crucial for the growth and survival of neoplastic cells. These cells are recruited by cytokines/chemokines. Lymphomas include a diverse group of tumors that invade various lymphoid structures and may originate from different types of lymphocytes at different stages of differentiation.

DIAGNOSTICS (2022)

Article Biochemistry & Molecular Biology

Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives

Alessandra Loda, Marta Turati, Francesco Semeraro, Sara Rezzola, Roberto Ronca

Summary: Ocular tumors are rare neoplasms that develop in the eye. Current treatments can control the local tumor, but some patients develop metastatic disease. New targets and players are needed to prevent and control tumor growth and metastasis. The fibroblast growth factor/receptor system plays a relevant role in ocular tumors and may have prognostic and therapeutic implications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Genetics & Heredity

Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study

Gerardo Cazzato, Katia Mangialardi, Giovanni Falcicchio, Anna Colagrande, Giuseppe Ingravallo, Francesca Arezzo, Giovanna Giliberti, Irma Trilli, Vera Loizzi, Teresa Lettini, Sara Scarcella, Tiziana Annese, Paola Parente, Carmelo Lupo, Nadia Casatta, Eugenio Maiorano, Gennaro Cormio, Leonardo Resta, Domenico Ribatti

Summary: The use of PRAME as a tumor marker holds potential value in the diagnosis and immunotherapeutic approach to cancer. However, its specificity is lower and it may also be expressed in atypical lesions.

GENES (2022)

Review Oncology

Ten Years of CRISPRing Cancers In Vitro

Davide Capoferri, Serena Filiberti, Jessica Faletti, Camilla Tavani, Roberto Ronca

Summary: Understanding the characteristics of cancer cells is crucial for studying tumor biology. Both traditional cell lines and modern genome editing techniques have played important roles in cancer research.

CANCERS (2022)

Article Cell Biology

Tumor Microenvironment and Microvascular Density in Human Glioblastoma

Roberto Tamma, Giuseppe Ingravallo, Tiziana Annese, Antonio d'Amati, Loredana Lorusso, Domenico Ribatti

Summary: In this study, we analyzed biopsy specimens from adult patients with IDH1 wild type GBM and found that there was a significant increase in the number of total and M2 type macrophages, CD4(+)- and CD8(+)-lymphocytes, and CD34(+) microvessels in the tumor area compared to the healthy surrounding tissue. We also confirmed previous findings that there were higher numbers of p53 and BCL6(+) cells in the tumor area, with a positive correlation between BCL6 and CD34(+) microvessels. These results suggest that microenvironment components play an important role in GBM progression and could potentially be targeted for new therapies.

CELLS (2023)

Review Biochemistry & Molecular Biology

Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish

Luca Mignani, Jessica Guerra, Marzia Corli, Davide Capoferri, Marco Presta

Summary: Sphingolipidoses are inborn errors of metabolism caused by pathogenic mutations in genes involved in sphingolipid catabolism, leading to lysosomal accumulation of defective proteins. Zebrafish is a valuable model system for studying the pathogenesis and therapeutic approaches of sphingolipidoses.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation

Giuseppe Lucarelli, Giuseppe Stefano Netti, Monica Rutigliano, Francesco Lasorsa, Davide Loizzo, Martina Milella, Annalisa Schirinzi, Antonietta Fontana, Francesca Di Serio, Roberto Tamma, Domenico Ribatti, Michele Battaglia, Elena Ranieri, Pasquale Ditonno

Summary: MUC1 is overexpressed in clear cell renal cell carcinoma (ccRCC) and is associated with aggressive cancer phenotype and chemoresistance. This study found that MUC1 can regulate the immunoflammatory response in the tumor microenvironment by activating the classical pathway of the complement system and is associated with the expression of pentraxin-3 (PTX3). The results suggest that MUC1 expression can modulate the immune infiltration in the ccRCC microenvironment and promote the formation of an immune-silent microenvironment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Oncology

T Cell Immunoglobulin and Mucin Domain 3 (TIM-3) in Cutaneous Melanoma: A Narrative Review

Gerardo Cazzato, Eliano Cascardi, Anna Colagrande, Teresa Lettini, Alessandra Filosa, Francesca Arezzo, Carmelo Lupo, Nadia Casatta, Vera Loizzi, Cristina Pellegrini, Maria Concetta Fargnoli, Eugenio Maiorano, Gerolamo Cicco, Roberto Tamma, Giuseppe Ingravallo

Summary: T cell immunoglobulin and mucin domain 3 (TIM-3) is an inhibitory immunocheckpoint that has been investigated for its role in the tumour microenvironment of melanoma. This review provides the most up-to-date knowledge about TIM-3 in melanoma and discusses future prospects and potential applications.

CANCERS (2023)

Article Oncology

Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways

Domenico Ribatti, Roberto Tamma, Tiziana Annese, Antonio d'Amati, Giuseppe Ingravallo, Giorgina Specchia

Summary: Angiogenesis is the main mechanism for new blood vessel formation in tumors. Recent studies have shown that non-angiogenic pathways also play an important role in tumor resistance to anti-angiogenic therapies. This review discusses the current knowledge on vessel formation in lymphomas and its implications for prognosis and treatment.

CANCERS (2023)

Article Oncology

The Tumor Microenvironment in Classic Hodgkin's Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy

Roberto Tamma, Giuseppe Ingravallo, Francesco Gaudio, Antonio d'Amati, Pierluigi Masciopinto, Emilio Bellitti, Loredana Lorusso, Tiziana Annese, Vincenzo Benagiano, Pellegrino Musto, Giorgina Specchia, Domenico Ribatti

Summary: Although classical Hodgkin lymphoma (CHL) is generally curable, a significant percentage of patients experience relapse and succumb to the disease. The cellular microenvironment in CHL consists of a small number of H/RS tumor cells surrounded by various inflammatory cells. Understanding the interaction between H/RS cells and immune cells in the microenvironment could lead to new targeted immunotherapies. This study analyzed the microenvironment composition in CHL patients with responsive disease (RESP) and relapsed/refractory disease (REL). The results revealed differences in the abundance of specific immune cells and microvessels between RESP and REL patients.

CANCERS (2023)

Article Biochemistry & Molecular Biology

Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies

Paloma Begines, Alessandro Bonardi, Alessio Nocentini, Paola Gratteri, Simone Giovannuzzi, Roberto Ronca, Camilla Tavani, Maria Luisa Massardi, Oscar Lopez, Claudiu T. Supuran

Summary: This study successfully synthesized a variety of compounds that conjugate biotin with sulfonamide motifs and tested their efficacy as carbonic anhydrase inhibitors in vitro. Most of the synthesized compounds showed interesting inhibition profiles in the nanomolar range, and some compounds exhibited good selectivity towards tumor-associated enzymes. One compound demonstrated anti-proliferative activity in multiple tumor cell lines.

BIOORGANIC & MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Molecular Profiling of Lymphatic Endothelial Cell Activation In Vitro

Marta Turati, Gianluca Mattei, Alessia Boaretto, Alberto Magi, Maura Calvani, Roberto Ronca

Summary: The lymphatic vascular system plays a crucial role in cancer progression by activating lymphatic endothelial cells and facilitating the formation of new lymphatic vessels. This study revealed that cancer-derived and microenvironmental mediators activate specific molecular pathways in lymphatic endothelial cells, leading to endothelial activation, morphogenesis, and cytokine-mediated signaling. The findings provide new insights into the lymphangiogenesis process and its relevance in different types of tumors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

No Data Available